Special Considerations in the Management of HIV-Infected Patients From Minority Communities
Summary
- ARTEMIS study compared darunavir/ritonavir with lopinavir/ritonavir in treatment-naive patients also receiving emtricitabine/tenofovir DF[Andrade-Villanueva 2008]
- Efficacy did not differ by race
- Differences in the incidence of adverse events were not considered clinically relevant
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content